Press "Enter" to skip to content

Biocon Biologics, Viatris Inc. get CHMP nod for Abevmy, a biosimilar to Avastin

Abevmy is abiosimilar to Roche’s Avastin, prescribed for all indications including metastatic colorectal carcinoma, metastatic breast cancer, non-small-cell lung carcinoma, glioblastoma, ovarian, cervical and renal cancer as part of a specific regimen, it said.

Original source: https://health.economictimes.indiatimes.com/news/pharma/81268094?utm_source=RSS&utm_medium=ETRSS

Also Read:   Biocon Biologics appoints M.B. Chinappa as CFO